Sign in

CIK 0001623526

  • Non-accelerated filer
  • Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471144582
Phone
+1 781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$403,975
in 4 filings, $404K under 10b5-1 plans

Net −$403,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 79 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-03 Krainer Adrian R. Director Grant or award · Director Stock Option (Right to Buy) +17,786 17,786
2026-03-10 Krainer Adrian R. Director Sale 10b5-1 −33,243 $39.74 $1.3M 283,302
2026-03-02 Krainer Adrian R. Director Sale 10b5-1 −7,229 $39.66 $287K 316,545
2025-11-24 Krainer Adrian R. Director Sale 10b5-1 −40,472 $29.72 $1.2M 323,774
2025-11-14 Krainer Adrian R. Director Sale 10b5-1 −19,790 $26.61 $527K 384,928
2025-11-14 Krainer Adrian R. Director Sale 10b5-1 −20,682 $27.34 $565K 364,246
2025-06-03 Krainer Adrian R. Director Grant or award · Director Stock Option (Right to Buy) +29,747 29,747
2024-06-05 Krainer Adrian R. Director Grant or award · Director Stock Option (Right to Buy) +7,639 7,639
2023-06-13 Krainer Adrian R. Director Grant or award · Director Stock Option (Right to Buy) +19,441 19,441
2022-06-07 Krainer Adrian R. Director Grant or award · Director Stock Option (Right to Buy) +21,000 21,000

Page 1 of 1 · 10 trades